Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit

https://www.fiercebiotech.com/biotech/lillys-prevail-inks-15b-pact-doudnas-scribe-crispr-tech

BEGIN Berkeley Gateway to Innovation
portal to the UC Berkeley entrepreneurship community

Join the IPIRA Mailing List

Read the IPIRA Newsletter

Accessibility | Nondiscrimination | Privacy

© 2022 Regents of the University of California. All Rights Reserved.